TAVR: Is There Trouble in Paradise?
By Rajesh Dave I was the fortunate physician who had the privilege of performing the very first commercially approved Sapien valve procedure in the USA (2011). Since then, we have
How to Select the Right Patient for Long-Term DAPT
Issue of Debate at C3, June 17-20, 2018 Interventional Academy Speaks with Prof David Erlinge, MD, PhD, FESC, FACC, Head, Department of Cardiology, Lund, Sweden Treatment with dual antiplatelet therapy
TREAT: Are We One Step Closer?
TREAT: Are we one step closer? by Rajesh M. Dave, MD It is well established that Primary PCI in a timely fashion leads to the best outcomes in patients with…
Update: ODYSSEY Outcomes
Update on ODYSSEY Outcomes – by Dr. Rajesh Dave, MD, FSCAI, FACC ODYSSEY Outcomes, the second of the cardiovascular outcomes studies with a PCSK9 inhibitor, this time in an acute
Reflecting on International Women’s Day
By, Dr. Arasi Maran From struggling for our right to vote to now.. what an incredible journey it has been. Even in the field of medicine, women have struggled and…
Flu and Heart Attack Association in NEJM
Flu and Heart Attack Association in NEJM By Rajesh Dave, MD Data from CDC reports worst flu season in decade. CDC reports on their website “Among adults hospitalized with the
Management of ACS in the Elderly
by Ramesh Daggubati, MD With baby boomers living longer, a day does not pass without a physician wondering how to manage acute coronary syndrome in the elderly. Randomized controlled trials
New in Endovascular Thrombectomy for Stroke
AHA/ASA expands treatment window for percutaneous thrombectomy window to 24 hours in a newly released guideline at International Stroke Conference. The recommendation was based on DAWN & DEFUSE 3 trials.